THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Amgen near accord with hospital over drug royalty

By Christopher Rowland
Globe Staff / March 3, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Amgen Inc. said it has agreed to settle a dispute with Massachusetts General Hospital over royalties it pays the hospital for helping to invent Enbrel, Amgen's highly profitable drug to treat rheumatoid arthritis. (Full article: 353 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly